Goldridge Terminal 로고 Goldridge Terminal
인기
로그인

관심목록에 추가
Pro 차트

60 Degrees Pharmaceutical...

NasdaqCM: SXTPW · 실시간 가격 · USD
0.03
+0.00 (0.00%)
종가 기준: Aug 12, 2026, 3:29 PM

60 Degrees Pharmaceuticals Inc. (SXTPW) Stock Price, Analysis & Data

0.00%
매수호가n/a
시가총액n/a
매출 (ttm)n/a
순이익 (ttm)n/a
베타n/a
EPS (ttm)n/a
P/E (ttm)n/a
선행 P/En/a
P/B (ttm)-0.02
P/S (ttm)n/a
Earnings Daten/a
매도호가n/a
거래량5,552
평균 거래량 (20일)
시가0.05
전일 종가0.03
일중 범위0.03 - 0.03
52주 범위0.03 - 0.03
애널리스트n/a
목표주가n/a
배당n/a
배당락일n/a

SXTPW 소개

A detailed description of the company is not yet available....

[더 보기]
산업 n/a
섹터 n/a
IPO 일자 Jul 17, 2026
직원 수 n/a
상장 거래소 NasdaqCM
티커 SXTPW
전체 기업 정보

재무 실적

2025년 60 Degrees Pharmaceuticals의 매출은 1.01M로, 전년 607.57K 대비 65.49% 증가했습니다. 순이익은 -7.37M로, -7.32% 감소했습니다.

재무제표
news image

4개월 전 · Zacks

60 Degrees Pharmaceuticals Inc. (SXTP) Upgraded to Buy: Here's What You Should Know

60 Degrees Pharmaceuticals Inc. (SXTP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

news image

5개월 전 · Insider Monkey

60 Degrees Pharmaceuticals (SXTP) Partners With GoodRx to Expand Access to ARAKODA

60 Degrees Pharmaceuticals Inc. (NASDAQ:SXTP) is one of the best up and coming penny stocks to buy. On February 2, 60 Degrees Pharmaceuticals announced a partnership with GoodRx to enhance the afforda...

news image

11개월 전 · Clinical Trials Arena

60 Degrees to commence Phase II babesiosis trial at Mount Sinai

The trial aims to assess the regimen over a 90-day period for those with a presumptive diagnosis of the condition.

news image

11개월 전 · Simply Wall St.

60 Degrees Pharmaceuticals Second Quarter 2025 Earnings: Revenues Disappoint

60 Degrees Pharmaceuticals ( NASDAQ:SXTP ) Second Quarter 2025 Results Key Financial Results Revenue: US$307.9k (up...